Latest News and Press Releases
Want to stay updated on the latest news?
-
VANCOUVER, British Columbia, May 04, 2023 (GLOBE NEWSWIRE) -- Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF) today announced the launch in Germany of cannabis...
-
SOMERSET, N.J., May 04, 2023 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company” or “CareCloud”) (Nasdaq: CCLD, CCLDP and CCLDO), a leader in healthcare technology solutions for medical practices and...
-
Växjö, Sweden, 4 May 2023 * * * JLT Mobile Computers, a leading supplier of rugged computers for demanding environments, publishes its interim report for the period January–March 2023 today. A...
-
Veðskuldabréfasjóður ÍV: Umframgreiðsla VIV 14 1 Með vísan í lýsingu og skilmála skuldabréfaflokksins VIV 14 1 hefur Veðskuldabréfasjóður ÍV, sem útgefandi, ákveðið að nýta sér heimild...
-
The application is based on phase 3 results from the ReOpen clinical trial program showing XHANCE significantly reduced symptoms and sinus opacification in participants with chronic rhinosinusitis If...
-
Total Digital Revenue(1) totaled $65M (+12% YOY)Digital-only subscribers total 596,000 (+21% YOY) with revenue +39% YOYAmplified Digital® revenue totaled $22M in the fiscal quarter (+20% YOY)Reaffirms...
-
ATLANTA, May 04, 2023 (GLOBE NEWSWIRE) -- SweetWater Brewing Company, LLC (“SweetWater Brewing” or “SweetWater”), a subsidiary of Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ: TLRY and...
-
Press Release Nokia wins nationwide 5G RAN deal with Orange Jordan Nokia wins deal to deploy 5G network with equipment from its latest AirScale Baseband and Radio portfolio including Nokia's...
-
- IMAN demonstrated potent direct killing of a patient derived pancreatic ductal adenocarcinoma tumouroid model - IMAN is the world’s first neutrophil-based cell therapy, generated...
-
Multiple Additional Indications Possible, Including Autoimmune Diseases: Pipeline within a Product Published Non-Human Primate Studies Show TNX-1500 Prolongs Renal and Heart Allograft Survival Phase...